These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3630280)

  • 1. [Characterization of functional disorders of bone marrow by measuring chemiluminescence].
    Reinhardt U; Reinhardt U; Rudolph E; Fleischer J
    Z Gesamte Inn Med; 1987 Jun; 42(12):341-3. PubMed ID: 3630280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow toxicity of chemotherapy combinations in operable carcinoma of the breast].
    Mano MP; Barengo R; Sinistrero G; Giurgola L; Sismondi P
    Minerva Ginecol; 1985 Jun; 37(6):335-8. PubMed ID: 4034081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone marrow toxicity of the chemotherapy of gynecological tumors].
    Sismondi P; Giai M; Mano MP; Catolla Cavalcanti T; Lamberto A
    Minerva Ginecol; 1985; 37(1-2):27-30. PubMed ID: 4011025
    [No Abstract]   [Full Text] [Related]  

  • 4. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemiluminescence measurements of immune cells--a tool in immunobiology and clinical research.
    Ernst M; Heberer M; Fischer H
    J Clin Chem Clin Biochem; 1983 Sep; 21(9):555-60. PubMed ID: 6355369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic disorders of granulocyte function].
    Rister M; Suttorp M
    Beitr Infusionther Klin Ernahr; 1986; 15():268-76. PubMed ID: 3019298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Farquhar disease. Reduced phagocyte function in a 9-year-old girl with erythrophagocytic lymphohistiocytosis].
    Schroten H; Kampmann A; Sperzel M; Jürgens H; Seger R; Wahn V
    Monatsschr Kinderheilkd; 1992 Jun; 140(6):336-9. PubMed ID: 1640943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of luminol-enhanced chemiluminescence induced in murine splenocytes and bone marrow cells by various stimulating agents.
    Cíz M; Lojek A
    Folia Biol (Praha); 1993; 39(2):106-16. PubMed ID: 8258368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
    Hofmann M; Mahlke M; Casper F; Brockerhoff P
    Zentralbl Gynakol; 1995; 117(6):314-6. PubMed ID: 7544054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemiluminescence of granulocytes and monocytes in diluted whole blood samples: a tumor marker?
    Heberer M; Ernst M; Dürig M; Harder F
    Cancer Detect Prev; 1983; 6(1-2):273-80. PubMed ID: 6309386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.
    Bjelic-Radisic V; Stöger H; Winter R; Beham-Schmid C; Petru E
    Anticancer Res; 2006; 26(2B):1627-30. PubMed ID: 16619583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lysozyme and cytostatic therapy].
    Neretto G; Giovanelli E; Agricola R; Pellegrino S; Bruno F; Mangione M; Furno F
    Clin Ter; 1978 Dec; 87(5):465-73. PubMed ID: 737983
    [No Abstract]   [Full Text] [Related]  

  • 13. Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia.
    Scholz M; Engel C; Loeffler M;
    Br J Haematol; 2006 Mar; 132(6):723-35. PubMed ID: 16487172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant.
    Myers SE; Mick R; Williams SF
    Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow responsiveness and mechanisms of hematopoietic regulation in animals with prior cytostatic disease].
    Bogdashin IV; Novitskiĭ VV; Sycheva EV; Afanas'eva ON; Kolmogorova LA; Sherstoboev EIu; Zhdanov VV; Iurkina OIu
    Patol Fiziol Eksp Ter; 1994; (1):7-9. PubMed ID: 8183603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostication of hematotoxicity for radio- and chemotherapy in patients with breast cancer].
    Ivanov SD; Iamshanov VA; Korytova LI; Khazova TV; Arzumanov AS
    Vopr Onkol; 2003; 49(5):601-7. PubMed ID: 14682132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
    Peters WP
    Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
    [No Abstract]   [Full Text] [Related]  

  • 18. Circadian fluctuations in the activity of phagocytic cells in blood, spleen, and peritoneal cavity of mice as measured by zymosan-induced chemiluminescence.
    Knyszynski A; Fischer H
    J Immunol; 1981 Dec; 127(6):2508-11. PubMed ID: 7299134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional capacity of marginated and bone marrow reserve granulocytes.
    Steele RW; Steele CR; Pilkington NS; Charlton RK
    Infect Immun; 1987 Oct; 55(10):2359-63. PubMed ID: 3653982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural-functional state of the genetic apparatus of blood leukocytes in breast cancer patients during cytostatic therapy].
    Ishkhanova MA; Mitriaeva NA; Gaĭseniuk LA
    Vopr Med Khim; 1985; 31(5):110-2. PubMed ID: 4090353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.